UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (647) 647
Newspaper Article (76) 76
Newsletter (46) 46
Book Chapter (29) 29
Transcript (9) 9
Dissertation (7) 7
Magazine Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pertuzumab (805) 805
breast cancer (457) 457
science & technology (396) 396
life sciences & biomedicine (390) 390
trastuzumab (372) 372
oncology (315) 315
humans (270) 270
cancer (236) 236
female (235) 235
breast neoplasms - drug therapy (184) 184
her2 (161) 161
care and treatment (152) 152
metastasis (150) 150
chemotherapy (148) 148
research (136) 136
receptor, erbb-2 - metabolism (122) 122
lapatinib (118) 118
health aspects (115) 115
skin and connective tissue diseases (109) 109
breast neoplasms - pathology (107) 107
drug therapy (96) 96
erbb-2 protein (95) 95
epidermal growth factor (93) 93
antineoplastic combined chemotherapy protocols - therapeutic use (92) 92
receptor, erbb-2 - antagonists & inhibitors (82) 82
cancer therapies (81) 81
antibodies, monoclonal, humanized - administration & dosage (80) 80
middle aged (78) 78
oncology, experimental (73) 73
antibodies, monoclonal, humanized - therapeutic use (72) 72
antineoplastic agents - therapeutic use (70) 70
patients (69) 69
analysis (66) 66
breast neoplasms - metabolism (66) 66
tumors (64) 64
adult (62) 62
aged (62) 62
medicine & public health (62) 62
neoplasms (62) 62
metastatic breast cancer (61) 61
t-dm1 (61) 61
clinical trials (60) 60
metastases (57) 57
animals (56) 56
pharmacology & pharmacy (55) 55
dosage and administration (53) 53
treatment outcome (53) 53
women (52) 52
receptor, erbb-2 - genetics (51) 51
monoclonal antibodies (48) 48
trastuzumab - administration & dosage (46) 46
cancer patients (44) 44
adjuvant treatment (43) 43
medical research (42) 42
prognosis (42) 42
antibodies, monoclonal, humanized (40) 40
biotechnology industry (39) 39
drug approval (39) 39
antibodies, monoclonal, humanized - adverse effects (38) 38
drug therapy, combination (38) 38
neoplasms. tumors. oncology. including cancer and carcinogens (38) 38
carboplatin (37) 37
neoadjuvant therapy (37) 37
surgery (37) 37
breast neoplasms - genetics (36) 36
immunotherapy (36) 36
medical prognosis (36) 36
molecular targeted therapy (36) 36
trastuzumab emtansine (36) 36
antibodies, monoclonal - therapeutic use (35) 35
antineoplastic combined chemotherapy protocols - adverse effects (35) 35
fda approval (35) 35
neratinib (35) 35
development and progression (34) 34
docetaxel (34) 34
cell line, tumor (33) 33
pharmaceutical industry (33) 33
product development (33) 33
antibodies, monoclonal, humanized - pharmacology (32) 32
disease-free survival (32) 32
ovarian cancer (32) 32
proteins (32) 32
immunohistochemistry (31) 31
kinases (31) 31
review (31) 31
trastuzumab - therapeutic use (31) 31
antineoplastic agents - pharmacology (30) 30
medicine, experimental (30) 30
medicine, research & experimental (30) 30
research & experimental medicine (30) 30
biomarkers (29) 29
taxoids - administration & dosage (29) 29
breast neoplasms - mortality (28) 28
genetic aspects (28) 28
human epidermal growth factor receptor 2 (28) 28
medicine (28) 28
neoplasm metastasis (28) 28
bevacizumab (27) 27
biological products (26) 26
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (790) 790
French (8) 8
Russian (8) 8
Czech (3) 3
Japanese (3) 3
Chinese (2) 2
German (2) 2
Bosnian (1) 1
Polish (1) 1
Slovenian (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of oncology, ISSN 0923-7534, 03/2018, Volume 29, Issue 3, pp. 646 - 653
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2015, Volume 372, Issue 8, pp. 724 - 734
Journal Article
Clinical cancer research, ISSN 1557-3265, 05/2008, Volume 14, Issue 9, pp. 2710 - 2716
Purpose: To evaluate safety and efficacy of trastuzumab with pertuzumab in patients with human epidermal growth factor receptor 2 (HER2)–positive metastatic... 
trastuzumab and pertuzumab | cardiac toxicity | HER2-positive breast cancer | Life Sciences & Biomedicine | Oncology | Science & Technology
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2012, Volume 366, Issue 2, pp. 109 - 119
Journal Article
Cancer biology & therapy, ISSN 1555-8576, 11/2018, Volume 20, Issue 2, pp. 192 - 200
Journal Article
10/2019
Transcript
Reviews on recent clinical trials, ISSN 1574-8871, 09/2017, Volume 12, Issue 3, pp. 216 - 222
Journal Article
05/2019
Transcript
The Journal of clinical investigation, ISSN 0021-9738, 01/2020, Volume 130, Issue 1, p. 231
The c-MYC (MYC) oncoprotein is often overexpressed in human breast cancer; however, its role in driving disease phenotypes is poorly understood. Here, we... 
Pertuzumab | Health aspects | Breast cancer
Journal Article